Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance

Elevance Health, Inc. (NYSE:ELV) is one of the 11 Best Roth IRA Stocks to Invest in Now.

Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance

Elevance Health, Inc. (NYSE:ELV) announced on September 4, 2025, that it expects to reaffirm its full-year 2025 earnings guidance during upcoming investor meetings. The company expects earnings of roughly $24.10 per diluted share, including roughly $5.90 per share in net unfavorable items. Excluding these, adjusted earnings of roughly $30.00 per diluted share are expected.

Furthermore, Elevance Health, Inc. (NYSE:ELV) also expects to achieve a benefit expense ratio close to 90% for the year. The company bases its projections on the current views on market conditions, regulatory factors, and medical cost trends.

With its Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands, Elevance Health, Inc. (NYSE:ELV) provides health benefits, pharmacy, and healthcare services across the U.S. It is one of the Best Roth IRA Stocks.

While we acknowledge the potential of ELV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ELV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Benefit From AI and 10 Must-Buy Canadian Stocks to Invest in.

Disclosure: None.